{"address1": "1900 Lake Park Drive", "address2": "Suite 380", "city": "Smyrna", "state": "GA", "zip": "30080", "country": "United States", "phone": "(678) 384-7220", "fax": "(678) 384-7281", "website": "https://www.geovax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; other infectious disease vaccines for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.", "fullTimeEmployees": 17, "companyOfficers": [{"maxAge": 1, "name": "Mr. David Alan Dodd", "age": 74, "title": "Chairman, President & CEO", "yearBorn": 1950, "fiscalYear": 2023, "totalPay": 384200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark J. Newman Ph.D.", "age": 69, "title": "Chief Scientific Officer", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 291500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kelly T. McKee Jr., M.D., M.P.H.", "age": 73, "title": "Chief Medical Officer", "yearBorn": 1951, "fiscalYear": 2023, "totalPay": 361034, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Harriet Latham Robinson Ph.D.", "age": 86, "title": "Founder, Chief Scientific Officer Emeritus & Member of Scientific Advisory Board", "yearBorn": 1938, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark W. Reynolds CPA", "age": 62, "title": "CFO & Corporate Secretary", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 348200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  O'Brien", "title": "Vice President of Quality Systems & Compliance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffrey  Welch", "title": "Head of Process Development & Manufacturing Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. John W. Sharkey Ph.D.", "age": 68, "title": "Vice President of Business Development", "yearBorn": 1956, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.geovax.com/investors/stock_chart.php", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.06, "open": 1.1, "dayLow": 1.03, "dayHigh": 1.1398, "regularMarketPreviousClose": 1.06, "regularMarketOpen": 1.1, "regularMarketDayLow": 1.03, "regularMarketDayHigh": 1.1398, "payoutRatio": 0.0, "beta": 3.07, "forwardPE": -1.255814, "volume": 328415, "regularMarketVolume": 328415, "averageVolume": 620171, "averageVolume10days": 450120, "averageDailyVolume10Day": 450120, "bid": 1.02, "ask": 1.1, "bidSize": 5, "askSize": 5, "marketCap": 10190956, "fiftyTwoWeekLow": 1.03, "fiftyTwoWeekHigh": 11.18, "priceToSalesTrailing12Months": 3.297872, "fiftyDayAverage": 1.629, "twoHundredDayAverage": 2.470575, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3391284, "profitMargins": 0.0, "floatShares": 8895948, "sharesOutstanding": 9436070, "sharesShort": 610609, "sharesShortPriorMonth": 762644, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0647, "heldPercentInsiders": 0.00322, "heldPercentInstitutions": 0.056739997, "shortRatio": 0.83, "shortPercentOfFloat": 0.065, "impliedSharesOutstanding": 9436070, "bookValue": 0.988, "priceToBook": 1.0931175, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -24322050, "trailingEps": -4.82, "forwardEps": -0.86, "lastSplitFactor": "1:15", "lastSplitDate": 1706659200, "enterpriseToRevenue": 1.097, "enterpriseToEbitda": -0.139, "52WeekChange": -0.443299, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.08, "targetHighPrice": 20.0, "targetLowPrice": 8.0, "targetMeanPrice": 14.6, "targetMedianPrice": 15.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 8592523, "totalCashPerShare": 0.911, "ebitda": -24397688, "totalDebt": 0, "quickRatio": 3.504, "currentRatio": 4.167, "totalRevenue": 3090161, "revenuePerShare": 0.945, "returnOnAssets": -1.12097, "returnOnEquity": -2.76023, "grossProfits": -19249188, "freeCashflow": -19251946, "operatingCashflow": -27199906, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -2.0988, "financialCurrency": "USD", "symbol": "GOVX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -4.82, "epsForward": -0.86, "fiftyDayAverageChange": -0.5489999, "fiftyDayAverageChangePercent": -0.33701652, "twoHundredDayAverageChange": -1.390575, "twoHundredDayAverageChangePercent": -0.5628548, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "marketState": "PRE", "regularMarketChangePercent": 1.886802, "regularMarketPrice": 1.08, "shortName": "GeoVax Labs, Inc.", "longName": "GeoVax Labs, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601040600000, "preMarketChange": 0.01999998, "preMarketChangePercent": 1.85185, "preMarketPrice": 1.1, "regularMarketChange": 0.0200001, "regularMarketDayRange": "1.03 - 1.1398", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 620171, "fiftyTwoWeekLowChange": 0.05000007, "fiftyTwoWeekLowChangePercent": 0.04854376, "fiftyTwoWeekRange": "1.03 - 11.18", "fiftyTwoWeekHighChange": -10.1, "fiftyTwoWeekHighChangePercent": -0.90339893, "fiftyTwoWeekChangePercent": -44.3299, "dividendDate": 1600992000, "earningsTimestamp": 1743105600, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747425600, "earningsCallTimestampStart": 1743107400, "earningsCallTimestampEnd": 1743107400, "isEarningsDateEstimate": true, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketTime": 1743595520, "regularMarketTime": 1743537601, "exchange": "NCM", "messageBoardId": "finmb_12056751", "displayName": "GeoVax Labs", "trailingPegRatio": null}